A detailed history of Panagora Asset Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 27,231 shares of AXSM stock, worth $2.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,231
Holding current value
$2.44 Million
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$78.93 - $95.84 $2.15 Million - $2.61 Million
27,231 New
27,231 $2.45 Million
Q2 2022

Aug 15, 2022

BUY
$21.74 - $46.75 $167,289 - $359,741
7,695 Added 60.5%
20,415 $782,000
Q1 2022

May 12, 2022

BUY
$23.7 - $41.39 $301,464 - $526,480
12,720 New
12,720 $526,000
Q4 2020

Feb 10, 2021

SELL
$66.31 - $86.52 $483,466 - $630,817
-7,291 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$68.34 - $85.84 $242,948 - $305,161
-3,555 Reduced 32.78%
7,291 $519,000
Q2 2020

Aug 12, 2020

BUY
$49.87 - $98.69 $540,890 - $1.07 Million
10,846 New
10,846 $892,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.85B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.